STOCK TITAN

VERADIGM INC - $MDRX STOCK NEWS

Welcome to our dedicated page for VERADIGM news (Ticker: $MDRX), a resource for investors and traders seeking the latest updates and insights on VERADIGM stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect VERADIGM's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of VERADIGM's position in the market.

Rhea-AI Summary
Veradigm Inc. (MDRX) debuts Veradigm Payer Insights solution at ViVE 2024 conference, delivering care gap alerts to providers within EHR systems. The solution aims to enhance patient care outcomes by addressing gaps in care delivery, highlighting the company's commitment to driving improved clinical and financial outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.33%
Tags
none
-
Rhea-AI Summary
Veradigm Inc. (NASDAQ: MDRX) released its inaugural Veradigm Insights Report: Cardiovascular Conditions in 2024, analyzing de-identified data for 53 million unique cardiovascular patients. The report reveals the South as having the highest rates of hypertension, coronary artery disease, and heart failure. Utilizing NLP on structured and unstructured data, the report provides insights on CVD prevalence across all 50 states and various demographics, aiding in patient management and early intervention.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.09%
Tags
none
-
Rhea-AI Summary
Veradigm Inc. (NASDAQ: MDRX) launches TRANSFORM VAX initiative to improve cardiovascular health through influenza vaccination education. The initiative aims to reduce major adverse cardiovascular events by 34% and 45% among individuals with recent acute coronary syndrome. Veradigm collaborates with the American College of Cardiology to deliver vaccination education messaging to cardiology practices using Practice Fusion EHR. The initiative utilizes real-world data to target healthcare providers meeting specific criteria set by ACC.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.29%
Tags
none
Rhea-AI Summary
Veradigm Inc. (MDRX) Refreshes Estimated Financial Information for Fiscal 2023: Revenue estimated between $608M and $622M, Adjusted EBITDA between $122M and $135M, and Net Cash to exceed $232M.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.36%
Tags
-
Rhea-AI Summary
MedAllies (NASDAQ: MDRX) partners with Veradigm Inc. to improve interoperability and treatment decisions for healthcare providers using Veradigm's EHRs. The partnership aims to provide access to longitudinal patient records, medical history, and medication lists, resulting in better point-of-care decision-making and improved interoperability throughout the healthcare industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.01%
Tags
none
-
Rhea-AI Summary
Veradigm Inc. (MDRX) to present at the 42nd Annual J.P. Morgan Healthcare Conference, providing an update on business and growth strategy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.41%
Tags
management conferences
Rhea-AI Summary
Veradigm Inc. (NASDAQ: MDRX) announces the acquisition of Koha Health, a full-service revenue cycle management company, to enhance its revenue cycle services portfolio in the ambulatory healthcare market. The acquisition brings Musculoskeletal Medicine specialty expertise and the ability to deliver revenue cycle services to ambulatory healthcare provider practices and ambulatory surgical centers utilizing various electronic health record systems.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.21%
Tags
-
Rhea-AI Summary
Veradigm Inc. (NASDAQ: MDRX) received a decision from the Nasdaq Hearings Panel granting its request for continued listing on the Nasdaq Capital Market, subject to compliance with Nasdaq Listing Rule 5250(c)(1) by February 27, 2024, and other conditions. The company remains noncompliant due to the non-filing of its Annual Report on Form 10-K for 2022 and Quarterly Reports on Form 10-Q for 2023. The Panel Decision has no immediate effect on the listing of the company’s common stock on the Nasdaq Global Select Market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.1%
Tags
none
-
Rhea-AI Summary
Veradigm Inc. (NASDAQ: MDRX) announced the launch of a conversational AI agent for Practice Fusion Billing Services, aimed at simplifying the billing process and optimizing financial management for independent healthcare providers. The AI, integrated with Microsoft and Zammo.ai software, provides instant conversation responses and feedback, trained in a closed system to generate real-time responses based on a comprehensive billing knowledge base.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
AI
Rhea-AI Summary
Veradigm Inc. (Nasdaq: MDRX) announced the appointment of Greg Garrison as Executive Chairman, Dr. Shih-Yin Ho as interim CEO, and Lee Westerfield as interim CFO. These changes are a result of an ongoing independent investigation related to financial reporting and internal controls. The company aims to strengthen its financial control environment and enhance financial reporting policies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20.02%
Tags
management
VERADIGM INC

Nasdaq:MDRX

MDRX Rankings

MDRX Stock Data

828.83M
69.64M
1.32%
128.9%
Computer Systems Design Services
Professional, Scientific, and Technical Services
Link
United States of America
Chicago

About MDRX

allscripts (nasdaq: mdrx) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. our innovative solutions connect people, places and data across an open, connected community of health™. connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. to learn more, visit www.allscripts.com, twitter, youtube and blog.allscripts.com.